Becker Capital Management Inc. Takes $1.58 Million Position in Teleflex Incorporated (NYSE:TFX)

Becker Capital Management Inc. acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 8,890 shares of the medical technology company's stock, valued at approximately $1,582,000.

Other institutional investors also recently bought and sold shares of the company. Headlands Technologies LLC acquired a new stake in shares of Teleflex in the 4th quarter worth $29,000. Avior Wealth Management LLC lifted its position in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc boosted its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after purchasing an additional 217 shares in the last quarter. Exchange Traded Concepts LLC increased its position in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares during the period. Finally, R Squared Ltd acquired a new position in Teleflex during the 4th quarter worth approximately $64,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Teleflex stock traded up $0.43 during mid-day trading on Friday, hitting $126.30. 753,291 shares of the company were exchanged, compared to its average volume of 638,279. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The business's 50 day simple moving average is $135.82 and its two-hundred day simple moving average is $170.33. The company has a market capitalization of $5.86 billion, a P/E ratio of 25.11, a PEG ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the business posted $3.21 EPS. Analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.08%. The ex-dividend date was Friday, March 7th. Teleflex's payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on TFX shares. Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Morgan Stanley lowered their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Truist Financial decreased their price objective on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Mizuho set a $155.00 target price on shares of Teleflex in a research report on Wednesday, April 16th. Finally, Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $167.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.